Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
about
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseClinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic reviewGemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)Increased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trialsGemcitabine eliminates double minute chromosomes from human ovarian cancer cellsPhase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.Comparison of vinorelbine-Cisplatin with gemcitabine-Cisplatin in patients with advanced non-small cell lung cancer.Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer.A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.Gemcitabine for the treatment of advanced nonsmall cell lung cancerTranscripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).Platinum drugs in the treatment of non-small-cell lung cancerLung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Chemotherapy of lung cancer: A global perspective of the role of ifosfamideUpfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma.Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based AnalysisEvaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine.Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerFirst-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer.Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerTreatment of non-small cell lung cancer (NSCLC).The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatmentUse of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
P2860
Q24200518-ED3A6BA4-2840-4761-AD09-9A30E207E5A0Q24243664-F656219E-E3D5-40C5-B757-A889FE3F656DQ24678961-AB204A8D-2403-4B4C-BB84-F4B4F1A98CB9Q28364865-BEE3967B-B722-4D4E-9E23-4E2A1E43EC92Q28533753-6179F0AC-ACD3-4010-BF2C-35D2C2F3668DQ28535582-05F71F5A-9469-42D3-AD4D-FCAA80611CF8Q33334597-0F429DBB-B2A6-464C-87A6-1856EFA171E4Q33334777-19D6A09E-1037-4790-A6C4-2A2D231B3053Q33338040-E2C9406B-7E0C-446D-845F-6EEBFBCC7009Q33343275-BEAAEE88-5A59-4544-B9FC-196F01985E66Q33343719-60DF6453-3904-4E58-9610-D9036B19AA4AQ33348744-702319F3-D672-4D89-8CA5-4790369371AAQ33366782-CBE44B9A-2EA0-47E1-B1F7-21866E67F2F2Q33393287-8C3C7DEC-8CC2-4B54-A152-BA36CADB0DAEQ33408330-F53A6A6B-250B-42BB-8486-1B6E0B8308AFQ33430874-BB27E236-FA18-47C6-BC0F-C246709C4033Q33915997-B4BAC8E9-E08C-4BC5-BD64-64D9A84A2AE5Q34203414-EF62C959-4A95-46B5-9C58-CF0811D84093Q34325219-526ABBF2-6791-46A0-AEA9-8DDEED0152DCQ34791240-22DB4A75-987C-4C8C-9F6A-58974A9B180BQ34954760-F0047239-1CC3-48E3-AA43-D4397BCCEDA3Q35096015-5DEBA31F-4F13-4F67-9107-0837BCE2FD56Q35200383-A090AC31-28B5-4906-8ECE-A3536EF91EDAQ35845236-D273CC9D-2998-4721-85EF-A8171752721EQ36040002-687CA46B-C852-4FA6-AF44-54A42EA018D2Q36140948-67921BE6-ACD8-4F46-B5B6-922B4ABD2D7DQ36386649-73935D36-F00C-4FD8-912A-0F55E304D109Q36614907-10524755-C2AA-49EA-B2FD-9DC6F516F856Q36643732-80B178D7-6715-499B-81FB-7A92186C6686Q36671151-608BAE17-75B2-4C1A-900E-043993E47712Q36975137-1D534C77-FBDE-4898-A376-3B0FDCA2CD64Q37355007-E731C2F1-CA78-478E-8963-97D259AB87C9Q38150348-018AECF1-26A1-40A8-BBF1-495B8FA1F4E7Q38226821-9CD03CE6-F75F-4B22-902C-5278C02F1815Q38602994-3BFDD30E-8FA2-4BAE-9F48-1A6676B8F1D8Q38631350-A26C4B82-580C-4D7A-99F3-F3A44858B5E4Q38985337-31F00511-8A8A-4178-A3BC-7AE90DE9CDEFQ42730901-8CFEF3C1-D3C8-42E2-9DC0-5ADBB47238FA
P2860
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@ast
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@en
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@nl
type
label
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@ast
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@en
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@nl
prefLabel
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@ast
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@en
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@nl
P2093
P1476
Gemcitabine and cisplatin vers ...... e Italian Lung Cancer Project.
@en
P2093
A Ceribelli
A Ravaioli
C Gridelli
F De Marinis
F Di Costanzo
F Gozzelino
G Cruciani
G V Scagliotti
P304
P356
10.1200/JCO.1999.17.11.3522
P407
P577
1999-11-01T00:00:00Z